GENOMEWEB Interview of Ross Bundy, CRISPR QC™ CEO
With $1.6 million of seed funding recently added to its balance sheet, CRISPR QC™ is advancing the commercial development of its data analytics platform for gene editing. READ FULL ARTICLE HERE The San Diego-based startup currently offers an in vitro CRISPR-based assay as a service to help customers gain insights into the performance of their […]
